PHARMADIRECT A/S: Financial statements 2015
CVR: 34221138
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PHARMADIRECT A/S (CVR 34221138) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -1,980,512 and a net result of DKK -3,621,243 compared with DKK -682,917 the year before. Equity in the 2015 report amounted to DKK 2,287,984. The solvency ratio was 74.2%.
- Gross Profit
- DKK -1,980,512
- Profit/Loss
- DKK -3,621,243
- Equity
- DKK 2,287,984
- Total Assets
- DKK 3,084,441
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -2 mio. | -3.6 mio. | 2.3 mio. | - |
| 2014 | - | -92 t. | -683 t. | 19.8 mio. | - |
| 2013 | - | -40 t. | -40 t. | 442 t. | - |
| 2012 | - | -18 t. | -18 t. | 482 t. | - |
Official annual report
How creditworthy is PHARMADIRECT A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PHARMADIRECT A/S has published its annual report for 2014. Gross profit came to DKK -91,813, and the net result was DKK -682,917.
About PHARMADIRECT A/S
PHARMADIRECT A/S was a Danish company of the type Aktieselskab based in Køge, founded in 2012. The company has been dissolved on 6 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named FARMADIRECT A/S. The company has 0 employees (2016). In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -29,034 compared with DKK -27,431 the year before. Equity in the 2022 report amounted to DKK 2,410,080.